Squarepoint Ops LLC Xeris Biopharma Holdings, Inc. Transaction History
Squarepoint Ops LLC
- $99.2 Billion
- Q4 2024
A detailed history of Squarepoint Ops LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 40,769 shares of XERS stock, worth $156,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,769
Previous 18,685
118.19%
Holding current value
$156,145
Previous $53,000
160.38%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$39.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$30.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$12.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$12.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$11 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $521M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...